Literature DB >> 31911669

Evolution in upfront treatment strategies for metastatic RCC.

Dominick Bossé1, Michael Ong2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31911669     DOI： 10.1038/s41585-019-0271-6

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Identification of a Gene Signature for Renal Cell Carcinoma-Associated Fibroblasts Mediating Cancer Progression and Affecting Prognosis.

Authors:  Bitian Liu; Xiaonan Chen; Yunhong Zhan; Bin Wu; Shen Pan
Journal:  Front Cell Dev Biol       Date:  2021-02-05

2.  Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Alice Tzeng; Tony H Tzeng; Moshe C Ornstein
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.